Christopher L. Amling, M.D., F.A.C.S
- click here
Dr. Amling specializes in treating cancers of the urinary and reproductive system, including the prostate, kidneys and bladder. He is an expert in minimally invasive cancer treatments, including robotic surgery for prostate and bladder cancer. Before coming to OHSU, Dr. Amling directed the Division of Urology at the University of Alabama at Birmingham, where he held the Anton J. Beuschen Chair in urologic surgery and research. Previously, he was chairman of the Department of Urology at the U.S. Naval Medical Center in San Diego.
Dr. Amling is a national and international authority on the latest prostate cancer treatments, including surgery with the da Vinci robotic system. He has also developed new ways to educate surgical residents and published many articles in medical journals on diagnosing and treating prostate cancer.
Dr. Amling, an Oregon native, was born in Coquille and graduated from the University of Oregon and OHSU School of Medicine. He is board certified in urology and is a fellow of the American College of Surgeons and a member of the American Urologic Association, which chose him for a prestigious award in 2009. Each year, the Gold Cystoscope Award goes to a urologist who has made important contributions to the specialty within 13 years of finishing residency training.
Other awards and honors include being elected president of the Society of University Urologists and serving on the editorial board of the Journal of Urology. Dr. Amling also reviews papers submitted for publication in the Journal of the American Medical Association, the Journal of Urology and Cancer and several other medical journals.
"Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: Results from the SEARCH database,"
"Detectable prostate-specific antigen nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: Results from the SEARCH database,"
"Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy,"
"Neoadjuvant chemotherapy use in bladder cancer: A survey of current practice and opinions,"